Sensus Healthcare of Boca Raton, FL at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine

Sensus Healthcare

851 Broken Sound Parkway NW #215, 33487 Boca Raton, FL
USA

This company is co-exhibitor of
Kuka Aktiengesellschaft

Hall map

MEDICA 2019 hall map (Hall 10): stand A22

Fairground map

MEDICA 2019 fairground map: Hall 10

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.03  Surgery devices, endoscopy devices
  • 01.03.12  Other surgical instruments and products

Our products

Product category: Other surgical instruments and products

SRT-100™ - A Sensitive Solution

y delivering a precise, calibrated dose of Superficial Radiation Therapy that only goes skin deep, patients can be safely treated right in their physician’s office. Each treatment is virtually painless.

Low-dose Superficial Radiation Therapy effectively destroys basal cell carcinoma and squamous cell carcinoma, as well as the non-malignant tumor cells that cause keloids. Best of all, it doesn’t involve cutting, bleeding or stitching. With the SRT-100™, there is no need for anesthesia, no risk of infection or scarring, no need for reconstructive plastic surgery. Patients heal quickly and don’t have downtime or lifestyle restrictions following treatment.

Sensus Healthcare’s SRT-100™ has been cleared by the U.S. Food and Drug Administration for the treatment of non-melanoma skin cancer and keloids. It is ideal for private dermatology and oncology practices, as well as hospitals and multi-locale healthcare providers.

More Less

Product category: Other surgical instruments and products

SRT-100+™ - A Sensitive Solution

The SRT-100+™—a state-of-the art system that is transforming the lives of people coping with non-melanoma skin cancer and unsightly keloid scars has been developed by Sensus Healthcare. This machine harnesses the remarkable healing power of Superficial Radiation Therapy to achieve remarkable results.

Designed with patients and physicians in mind, the SRT-100+™ is compact, mobile, and easy to use. Every patient deserves a choice–now they are able to choose a non-invasive, out-patient treatment option for non-melanoma skin cancer and keloids.

More Less

Product category: Other surgical instruments and products

SRT-100 VISION™ - See And Treat With The SRT-100 Vision™

or patients and physicians who want the ultimate in advanced Superficial Radiation Therapy technology, Sensus Healthcare offers the SRT-100 Vision™—the next generation of innovation in our powerful arsenal against non-melanoma skin cancer and unsightly keloid scarring.

Built with all the same great features and remarkable efficacy that distinguish the original SRT-100™, the SRT-100 Vision™ delivers the precise, painless calibrated dose of Superficial Radiation Therapy patients and physicians expect, but offers additional features—most notably high-frequency ultrasound for imaging.

With a high-frequency ultra-sound guidance system, the SRT-100 Vision™ allows physicians to view treatment areas while they are being treated. This “see and treat” capability allows basal and squamous cell carcinomas, as well as keloid tissue, to be assessed more thoroughly so treatment can be targeted more precisely. When the ultrasound technology is placed over the treatment area using the laser positioning system, physicians can assess the lesion to see how deep it is and fine tune the exact amount of radiation needed. This will ultimately help tailor each patient’s treatment protocol when physicians are able to see how the lesion is progressing with each treatment session. Not only this, but each treatment session is recorded for patient records with the LesionCam™.

The SRT-100 Vision™ offers physicians, institutions and healthcare systems great value on several levels. This compact, efficient and very effective mobile device makes it easy to serve new patients and more patients. By increasing patient volume, the SRT-100 Vision™ allows care providers to expand their reputation and footprint in the community. And by adding a non-surgical treatment option that delivers a 95 plus percent cure rate for non-melanoma cancer, along with a 94 plus percent cure rate for keloid scarring, the SRT-100 Vision™ helps reduce the overall cost of healthcare.

With a frequency of 22 MHz, treatment boundaries and margins can be better defined. In turn, better definition helps guide physicians with decisions about optimal treatment energy and applicator size.

More Less

Product category: Other surgical instruments and products

Introducing Sculptura™

State-Of-The-Art Radiation Oncology System With Revolutionary Beam Sculpting™, Fast Treatment Technology

Sensus Healthcare is pleased to introduce Sculptura™, a groundbreaking state-of-the-art, Modulated Robotic Brachytherapy IORT System. Sculptura™ is designed utilizing unique technology and advance features that set it apart from any other IORT system in the market. The unique design allows you to customize your beam, with fast treatment technology. Change the way you approach cancer treatment with this clinically innovative system.

The FDA cleared Sculptura™ modulated robotic brachytherapy radiation oncology system provides targeted intraoperative triple-modulated radiotherapy and Brachytherapy utilizing our proprietary, state-of-the-art 3D Beam Sculpting™ to treat patients undergoing cancer treatment during surgery, or at the tumor site, fast and efficiently.

More Less

About us

Company details

Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions. The recently introduced Sculptura™ robotic radiation oncology system provides targeted intraoperative triple-modulated radiotherapy (IORT) and Brachytherapy utilizing our proprietary, state-of-the-art 3D Beam Sculpting™ to treat patients undergoing cancer treatment during surgery, or at the tumor site, fast and efficiently.

Sensus also offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.

At Sensus Healthcare, we are devoted to making a difference in the lives of people who suffer from non-melanoma skin cancer and unsightly keloid scarring. By designing and manufacturing safe and reliable state-of-the-art Superficial Radiation Therapy technology right here in the United States, we are providing compassionate dermatologists and oncologists around the world with a non-surgical treatment option that empowers them to cure patients without compromising patient confidence, dignity or quality of life.

The compact and mobile SRT-100™ is making this standard of care accessible to more patients. Not only does the SRT meet stringent safety requirements set by the FDA, UL and ISO/CE Mark certification, it is backed by accomplished, ethical leadership and scientific case studies that are testaments to the SRT’s exceptional performance.

More Less